| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |